DrugPatentWatch Database Preview
Profile for Australia Patent: 2008207375
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Australia Patent: 2008207375
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 7, 2022 | Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |